Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
First Claim
Patent Images
1. A method for treating, inhibiting or preventing arterial restenosis in a mammal, which method comprises the steps of:
- (a) identifying a mammal that has an existing arterial restenosis or is at risk for developing arterial restenosis; and
(b) causing said mammal to inhale therapeutically effective concentration of gaseous NO; and
(c) administering to said mammal a therapeutically effective amount of a phosphodiesterase inhibitor without inducing acute systemic hypotension.
5 Assignments
0 Petitions
Accused Products
Abstract
Disclosed are methods of treating, inhibiting or preventing vascular thrombosis or arterial restenosis in a mammal. The disclosed methods include causing the mammal to inhale a therapeutically-effective concentration of gaseous nitric oxide (NO). Also disclosed are methods that include the administration of the following types of agents in conjunction with inhaled nitric oxide: compounds that potentiate the beneficial effects of inhaled nitric oxide, and antithrombotic agents that complement or supplement the beneficial effects of inhaled nitric oxide.
105 Citations
15 Claims
-
1. A method for treating, inhibiting or preventing arterial restenosis in a mammal, which method comprises the steps of:
-
(a) identifying a mammal that has an existing arterial restenosis or is at risk for developing arterial restenosis; and (b) causing said mammal to inhale therapeutically effective concentration of gaseous NO; and (c) administering to said mammal a therapeutically effective amount of a phosphodiesterase inhibitor without inducing acute systemic hypotension. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
-
Specification